Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society

August 15, 2011 By Bio-Medicine.Org

MINNETONKA, Minn., Aug. 15, 2011 /PRNewswire/ — Uroplasty, Inc.
(Nasdaq:
UPI
), a medical device company that develops, manufactures and
markets innovative proprietary products to treat voiding
dysfunctions, today announced that the results of two clinical
studies using Uroplasty’s Urgent® PC Neuromodulation System are
scheduled to be presented at the International Continence Society
meeting, August 29-September 2, 2011 in Glasgow, Scotland.
 

“These data from on-going clinical studies continue to
demonstrate the long-term efficacy of percutaneous tibial nerve
stimulation (PTNS) delivered via Urgent PC in the treatment of
overactive bladder syndrome,” said David Kaysen, President and CEO
of Uroplasty.  “The studies build on a growing body of
evidence that validates the treatment protocol, usefulness with
both young and elderly patients, and the durability of the
improvements with continued PTNS therapy.”  

ICS Presentations

SUmiT Trial Outcomes: Clinical Insights into Percutaneous Tibial
Nerve Stimulation
, presented by Dr. Peter Sand, NorthShore
University Health, Chicago, IL Demonstrated that results are
consistent for patients regardless of age Demonstrated that
improvement occurs throughout the series of 12 initial treatments,
with more improvement occurring during treatments 7 through
12Treatment Interval Frequency of Percutaneous Tibial Nerve
Stimulation: 18-Month Results from the STEP Study
, presented by
Dr. Kenneth Peters, William Beaumont Hospital, Royal Oak, MI
Responders to the initial series of 12 treatments treated with
regular PTNS therapy, on an average of once per month, sustained
their improvements in voiding symptoms and Quality of Life measures
throughout 18 months of therapy  

About Uroplasty Uroplasty, Inc., headquartered in Minnetonka,
Minnesota,

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech